UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.068

Sortiert nach

Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study

Neurology, 2008-11, Vol.71 (20), p.1572

2008

Volltextzugriff (PDF)

Clinical consequences of generic substitution of lamotrigine for patients with epilepsy

Neurology, 2008-05, Vol.70 (22 Pt 2), p.2179

2008

Volltextzugriff (PDF)

Generic antiepileptic drugs and associated medical resource utilization in the United States

Neurology, 2010-05, Vol.74 (20), p.1566

2010

Volltextzugriff (PDF)

The risks and costs of multiple-generic substitution of topiramate

Neurology, 2009-06, Vol.72 (24), p.2122

2009

Volltextzugriff (PDF)

Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial

European journal of cancer (1990), 2012-02, Vol.48 (3), p.311-323

2012

Volltextzugriff (PDF)

Persistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease

Journal of clinical pharmacy and therapeutics, 2012-04, Vol.37 (2), p.173-181

2012

Volltextzugriff (PDF)

In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty

Journal of medical economics, 2012-08, Vol.15 (4), p.644-653

2012

Volltextzugriff (PDF)

Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases

Prostate cancer and prostatic diseases, 2017-09, Vol.20 (3), p.276-282

2017

Volltextzugriff (PDF)

Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review study

Journal of endocrinological investigation, 2020-04, Vol.43 (4), p.529-538

2020

Volltextzugriff (PDF)

PATTERNS OF IMMUNOGLOBULIN G TESTING AND INFECTION OUTCOMES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING IMMUNOGLOBULIN REPLACEMENT THERAPY

Hematological oncology, 2023-06, Vol.41 (S2), p.744-745

2023

Volltextzugriff (PDF)

Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma

Leukemia, 2016-04, Vol.30 (4), p.995-998

2016

Volltextzugriff (PDF)

Clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) and mammalian target of rapamycin inhibitors (mTORI) after immuno-oncology (IO) checkpoint inhibitors

Annals of oncology, 2018-10, Vol.29, p.viii315-viii315

2018

Volltextzugriff (PDF)

P840: A MATCHING‐ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT‐NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

HemaSphere, 2022-06, Vol.6 (Suppl), p.734-735

2022

Volltextzugriff (PDF)

P1035: COUNTRY DIFFERENCES IN THE BURDEN OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE

HemaSphere, 2022-06, Vol.6 (Suppl), p.925-926

2022

Volltextzugriff (PDF)

P1034: HEALTHCARE UTILIZATION OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE

HemaSphere, 2022-06, Vol.6 (Suppl), p.924-925

2022

Volltextzugriff (PDF)

The role of provider characteristics on the hepatitis A and B vaccination status of adults in the United States during 2007–2015

Preventive medicine reports, 2019-06, Vol.14, p.100833-100833, Article 100833

2019

Volltextzugriff (PDF)

P1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

HemaSphere, 2022-06, Vol.6 (Suppl), p.903-904

2022

Volltextzugriff (PDF)

P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE

HemaSphere, 2022-06, Vol.6 (Suppl), p.904-905

2022

Volltextzugriff (PDF)

P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

HemaSphere, 2022-06, Vol.6 (Suppl), p.905-906

2022

Volltextzugriff (PDF)

Epidemiologic Interpretation of Artificial Neural Networks

American journal of epidemiology, 1998-06, Vol.147 (12), p.1112-1122

1998

Volltextzugriff (PDF)

Prediction and Cross-Validation of Neural Networks Versus Logistic Regression: Using Hepatic Disorders as an Example

American journal of epidemiology, 1998-02, Vol.147 (4), p.407-413

1998

Volltextzugriff (PDF)

The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia

Current medical research and opinion, 2005-10, Vol.21 (10), p.1677-1682

2005

Volltextzugriff (PDF)

Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs

Journal of the American Academy of Dermatology, 2006-03, Vol.54 (3), p.448-457

2006

Volltextzugriff (PDF)

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Hematological oncology, 2023-06, Vol.41 Suppl 2, p.744

2023

Volltextzugriff (PDF)

P621 Physician preferences for biologics (originator vs. biosimilar) for the treatment of ulcerative colitis in France, Germany and the UK

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S515-S516

2020

Volltextzugriff (PDF)

1 – 25 von 1.068

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(959)

Publikationsform

Sprache

Englisch
(1.063)
Japanisch
(113)
Französisch
(3)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study

Clinical consequences of generic substitution of lamotrigine for patients with epilepsy

Generic antiepileptic drugs and associated medical resource utilization in the United States

The risks and costs of multiple-generic substitution of topiramate

Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial

Persistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease

In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty

Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases

Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review study

PATTERNS OF IMMUNOGLOBULIN G TESTING AND INFECTION OUTCOMES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING IMMUNOGLOBULIN REPLACEMENT THERAPY

Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma

Clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) and mammalian target of rapamycin inhibitors (mTORI) after immuno-oncology (IO) checkpoint inhibitors

P840: A MATCHING‐ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT‐NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

P1035: COUNTRY DIFFERENCES IN THE BURDEN OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE

P1034: HEALTHCARE UTILIZATION OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE

The role of provider characteristics on the hepatitis A and B vaccination status of adults in the United States during 2007–2015

P1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE

P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

Epidemiologic Interpretation of Artificial Neural Networks

Prediction and Cross-Validation of Neural Networks Versus Logistic Regression: Using Hepatic Disorders as an Example

The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia

Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

P621 Physician preferences for biologics (originator vs. biosimilar) for the treatment of ulcerative colitis in France, Germany and the UK

Aktive Filter

Suchergebnisse filtern